AGM/EGMApr 29, 2026, 04:39 PM
DNA 2026 Annual Meeting Set for June 11; Director Elections, Auditor Vote
AI Summary
Ginkgo Bioworks Holdings, Inc. (DNA) announced its 2026 Annual Meeting of Shareholders will be held virtually on Thursday, June 11, 2026, at 8:00 a.m. Eastern Time. Shareholders of record as of April 15, 2026, are eligible to vote on proposals including the election of six director nominees, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and an advisory vote on executive compensation. Director Shyam Sankar will not be standing for re-election, leading to a reduction in board size from seven to six directors.
Key Highlights
- 2026 Annual Meeting of Shareholders scheduled for June 11, 2026, at 8:00 a.m. ET.
- Meeting will be held virtually at www.virtualshareholdermeeting.com/DNA2026.
- Shareholders of record as of April 15, 2026, are eligible to vote.
- Proposals include electing six director nominees to the Board.
- Ratification of Deloitte & Touche LLP as independent auditor for 2026.
- Advisory vote to approve executive compensation.
- Director Shyam Sankar is not standing for re-election.
- Board size expected to decrease from seven to six directors.
Price Impact
More from DNA